Tech Company Financing Transactions
BioSkryb Funding Round
Anzu Partners and Wilson Sonsini Goodrich & Rosati invested in a $11.5 million Seed funding round for BioSkryb. The round was announced by the company on 1/13/2020.
Transaction Overview
Company Name
Announced On
1/13/2020
Transaction Type
Venture Equity
Amount
$11,500,000
Round
Seed
Investors
Anzu Partners (Lead Investor) (David Michael)
Proceeds Purpose
The funding will accelerate BioSkryb's product roadmap and its commercialization efforts to enable enhanced levels of genomic and transcriptomic analyses for translational research and clinical diagnostics.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
701 W Main St. 200
Durham, NC 27701
USA
Durham, NC 27701
USA
Phone
Website
Email Address
Overview
Bioskryb is a venture-backed startup bringing new solutions for cellular heterogeneity, in both the research and clinical space studies, using a proprietary genome amplification system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay West
Co-Founder
Charles Gawad
Browse more venture capital transactions:
Prev: 1/13/2020: Inflammatix venture capital transaction
Next: 1/13/2020: Practifi venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs